Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage I-III curatively-treated Merkel cell carcinoma
•Efficacy of hypofractionated radiotherapy for Stage I-III Merkel cell carcinoma is not well-described.•There was no difference in cumulative incidence of in-field locoregional relapse or MCC-specific survival between hypofractionated and conventionally-fractionated radiotherapy.•On multivariable an...
Gespeichert in:
Veröffentlicht in: | Radiotherapy and oncology 2022-08, Vol.173, p.32-40 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!